TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 40 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12 | -45.5% | 18,077 | -33.9% | 0.00% | -50.0% |
| Q1 2023 | $22 | -94.7% | 27,338 | -85.1% | 0.00% | -96.2% |
| Q4 2022 | $416 | -99.9% | 183,857 | -22.1% | 0.05% | -13.3% |
| Q3 2022 | $456,000 | -34.3% | 236,120 | +26.6% | 0.06% | -42.3% |
| Q2 2022 | $694,000 | -9.2% | 186,480 | +59.2% | 0.10% | +1.0% |
| Q1 2022 | $764,000 | +60.5% | 117,109 | +186.4% | 0.10% | +71.7% |
| Q4 2021 | $476,000 | +6.2% | 40,885 | +104.4% | 0.06% | -20.0% |
| Q3 2020 | $448,000 | – | 20,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,000,000 | $53,080,000 | 57.48% |
| Octagon Capital Advisors LP | 320,440 | $8,504,000 | 2.95% |
| Alphabet Inc. | 640,882 | $17,009,000 | 0.82% |
| Casdin Capital, LLC | 820,440 | $21,774,000 | 0.64% |
| Artal Group S.A. | 1,040,882 | $27,625,000 | 0.59% |
| VR Adviser, LLC | 107,982 | $2,866,000 | 0.42% |
| Avidity Partners Management LP | 392,000 | $10,404,000 | 0.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $13,270,000 | 0.28% |
| Perceptive Advisors | 470,440 | $12,485,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 250,000 | $6,635,000 | 0.13% |